Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Graft-versus-host Disease (GvHD)
100%
Therapy-resistant
100%
Soluble Suppression of Tumorigenicity 2 (sST2)
100%
Transplantation
41%
Therapy Initiation
33%
Treatment-resistant
25%
Confidence Interval
16%
First Month
16%
6-month Mortality
16%
High Suppression
16%
Two-level
8%
Risk Stratification
8%
Day 14
8%
Complete Response
8%
Low Mortality
8%
Conditioning Regimen
8%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
8%
Disease Therapy
8%
Plasma Biomarkers
8%
Grade 11
8%
Medicine and Dentistry
Graft Versus Host Reaction
100%
Carcinogenicity
100%
Biological Marker
36%
Risk Stratification
9%
Combination Therapy
9%
Conditioning
9%
Acute Graft Versus Host Disease
9%
Allogeneic Hematopoietic Stem Cell Transplantation
9%
Nursing and Health Professions
Graft Versus Host Reaction
100%
Carcinogenicity
100%
Biological Marker
36%
Confidence Interval
18%
Combination Therapy
9%
Acute Graft Versus Host Disease
9%
Allogeneic Hematopoietic Stem Cell Transplantation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Carcinogenicity
100%
Biological Marker
36%
Combination Therapy
9%
Acute Graft Versus Host Disease
9%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Blood Plasma
45%
Conditioning
9%
Acute Graft Versus Host Disease
9%
Allogeneic Hematopoietic Stem Cell Transplantation
9%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Conditioning
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%